Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2
- PMID:23315425
- DOI: 10.1189/jlb.0912433
Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2
Abstract
Certain biogenic amines, such as 2-PEA, TYR, or T1AM, modulate blood pressure, cardiac function, brain monoaminergic systems, and olfaction-guided behavior by specifically interacting with members of a group of rhodopsin-like receptors, TAAR. A receptor that is absent from olfactory epithelia but had long been identified in the brain and a variety of peripheral tissues, TAAR1 has been found recently in blood B cells, suggesting a functional role of TAAR1 in these cells. With the present study, we have set out to clarify the expression and functional roles of TAAR in different isolated human blood leukocyte types. Here, we report the functional expression of TAAR1 and its closest relative TAAR2 in blood PMN and T and B cells. Both receptors are coexpressed in a subpopulation of PMN, where they are necessary for the chemosensory migration toward the TAAR1 ligands 2-PEA, TYR, and T1AM, with EC50 values of 0.43 ± 0.05 nM, 0.52 ± 0.05 nM, and 0.25 ± 0.04 nM, respectively. The same amines, with similar potencies, triggered cytokine or Ig secretion, in purified blood T or B cells, respectively. Notably, 2-PEA regulated mRNA expression of 28 T cell function-related genes, above all of the CCL5. In siRNA-guided experiments, TAAR1 and TAAR2 proved to be necessary for amine-induced blood leukocyte functions. In summary, our results demonstrate that biogenic amines potently regulate blood cell functions via TAAR1 and TAAR2 and open the perspective of their specific pharmacological modulation.
Similar articles
- Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis.Efimova EV, Kuvarzin SR, Mor MS, Katolikova NV, Shemiakova TS, Razenkova V, Ptukha M, Kozlova AA, Murtazina RZ, Smirnova D, Veshchitskii AA, Merkulyeva NS, Volnova AB, Musienko PE, Korzhevskii DE, Budygin EA, Gainetdinov RR.Efimova EV, et al.Front Behav Neurosci. 2022 Apr 1;16:847410. doi: 10.3389/fnbeh.2022.847410. eCollection 2022.Front Behav Neurosci. 2022.PMID:35431833Free PMC article.
- Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.Cöster M, Biebermann H, Schöneberg T, Stäubert C.Cöster M, et al.Eur Thyroid J. 2015 Sep;4(Suppl 1):9-20. doi: 10.1159/000430839. Epub 2015 May 29.Eur Thyroid J. 2015.PMID:26601069Free PMC article.
- Is there a role for biogenic amine receptors in mediating β-phenylethylamine and RO5256390-induced vascular contraction?Voisey AC, Broadley HD, Broadley KJ, Ford WR.Voisey AC, et al.Eur J Pharmacol. 2024 Oct 15;981:176895. doi: 10.1016/j.ejphar.2024.176895. Epub 2024 Aug 15.Eur J Pharmacol. 2024.PMID:39153650
- Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.Wu R, Li JX.Wu R, et al.CNS Drugs. 2021 Dec;35(12):1239-1248. doi: 10.1007/s40263-021-00871-4. Epub 2021 Nov 12.CNS Drugs. 2021.PMID:34766253Free PMC article.Review.
- Trace amine-associated receptors and their ligands.Zucchi R, Chiellini G, Scanlan TS, Grandy DK.Zucchi R, et al.Br J Pharmacol. 2006 Dec;149(8):967-78. doi: 10.1038/sj.bjp.0706948. Epub 2006 Nov 6.Br J Pharmacol. 2006.PMID:17088868Free PMC article.Review.
Cited by
- Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers.Fleischer LM, Somaiya RD, Miller GM.Fleischer LM, et al.Front Pharmacol. 2018 Jun 26;9:683. doi: 10.3389/fphar.2018.00683. eCollection 2018.Front Pharmacol. 2018.PMID:29997511Free PMC article.
- Extra-Oral Taste Receptors-Function, Disease, and Perspectives.Behrens M, Lang T.Behrens M, et al.Front Nutr. 2022 Apr 4;9:881177. doi: 10.3389/fnut.2022.881177. eCollection 2022.Front Nutr. 2022.PMID:35445064Free PMC article.Review.
- Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory Disorders.Christian SL, Berry MD.Christian SL, et al.Front Pharmacol. 2018 Jul 2;9:680. doi: 10.3389/fphar.2018.00680. eCollection 2018.Front Pharmacol. 2018.PMID:30013475Free PMC article.
- Evaluation of Approach to a Conspecific and Blood Biochemical Parameters in TAAR1 Knockout Mice.Zhukov IS, Ptukha MA, Zolotoverkhaja EA, Sinitca EL, Tissen IY, Karpova IV, Volnova AB, Gainetdinov RR.Zhukov IS, et al.Brain Sci. 2022 May 8;12(5):614. doi: 10.3390/brainsci12050614.Brain Sci. 2022.PMID:35625001Free PMC article.
- The Case for TAAR1 as a Modulator of Central Nervous System Function.Rutigliano G, Accorroni A, Zucchi R.Rutigliano G, et al.Front Pharmacol. 2018 Jan 10;8:987. doi: 10.3389/fphar.2017.00987. eCollection 2017.Front Pharmacol. 2018.PMID:29375386Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases